RidkerPM. A test in context: high-sensitivity C-reactive protein. J Am Coll Cardiol2016; 67: 712–723.
2.
LangsethMSOpstadTBBratsethVet al.Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease. Eur J Prev Cardiol2018. 25: 762–769.
3.
MartinodKWagnerDD. Thrombosis: tangled up in NETs. Blood2014; 123: 2768–2776.
4.
de BoerOJLiXTeelingPet al.Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost2013; 109: 290–297.
5.
MangoldAAliasSScherzTet al.Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res2015; 116: 1182–1192.
6.
QuillardTAraujoHAFranckGet al.TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. Eur Heart J2015; 36: 1394–1404.
7.
SoderbergDSegelmarkM. Neutrophil extracellular traps in ANCA-associated vasculitis. Front Immunol2016; 7: 256–256.
8.
BonaventuraALiberaleLCarboneFet al.The pathophysiological role of neutrophil extracellular traps in inflammatory diseases. Thromb Haemost2018; 118: 6–27.
9.
DaviesMJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation1996; 94: 2013–2020.
10.
EikelboomJWConnollySJBoschJet al.Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med2017; 377: 1319–1330.
11.
QuillardTFranckGMawsonTet al.Mechanisms of erosion of atherosclerotic plaques. Curr Opin Lipidol2017; 28: 434–441.
